Thursday, May 10, 2012

CAS - <span class="simulate_din_font">Cascades reports improved results for the first quarter of 2012</span> (CAD 0.04)

Company: Cascades Inc
Stock Name: CAS
Amount: CAD 0.04
Announcement Date: 10/05/2012
Record Date: 23/05/2012

Dividend Detail:




KINGSEY FALLS, QC, May 10, 2012 /CNW Telbec/ - Cascades Inc. (TSX: CAS),
a leader in the recovery and manufacturing of green packaging and
tissue paper products, announces its financial results for the
three-month period ended March 31, 2012.



Q1-2012 Financial Highlights




  • Sales of $891 million

    (compared to $913 million in Q4-2011 (-2%) and $774 million in Q1-2011
    (+15%))


  • Excluding specific items



    • EBITDA of $72 million

      (compared to $51 million in Q4-2011 (+41%) and $37 million in Q1-2011
      (+95%))


    • Net earnings per share of $0.04

      (compared to a net loss of $0.04 in Q4-2011 and net earnings of $0.01 in
      Q1-2011)



  • Including specific items



    • EBITDA of $75 million

      (compared to $37 million in Q4-2011 (+103%) and $30 million in Q1-2011
      (+150%))


    • Net earnings per share of $0.06

      (compared to net earnings of $0.05 in Q4-2011 and a net loss of $0.08 in
      Q1-2011)



  • Net debt of $1,524 million (compared to $1,485 million as at December
    31
    , 2011), including $173 million of non-recourse debt.




Strategic Initiatives




  • Acquisition of the corrugated boxes converting and warehousing
    facilities of Bird Packaging Limited located in Ontario.



  • Announcement of investments of $30 million and closures of three plants
    as part of the consolidation of our corrugated products sector in
    Ontario.



  • Consolidation of our honeycomb packaging manufacturing operations with
    the announced closure of Cascades Enviropac in Toronto.



  • Announcement of the closure of the Trenton containerboard mill effective
    June 1, 2012 due to financial losses and unsatisfactory labor
    relations.









Commenting on the first quarter results, Mr. Alain Lemaire, President
and Chief Executive Officer stated: "We announce today financial
results which are a significant improvement over the previous quarter
and the same period last year. This performance is below our
expectations due to a low level of productivity of our Containerboard
manufacturing operations. Our Tissue Papers Group continues to perform
well and our Specialty Products Group shows improved results. During
this past quarter, we benefited from lower recycled fibre costs and
average selling prices have held for most of our products despite
volatile demand. Continuing to implement our action plan, we have been
particularly active with restructuring and capital allocation measures
aimed at modernizing our operating units. The actions taken by our team
reflect our commitment to improve profitability and efficiency in an
increasingly competitive market."



Looking ahead in the near-term, Mr. Lemaire added: "The economic
environment remains difficult but seems to be gaining momentum in North
America
which is encouraging as we enter what have been historically
our two strongest quarters of the year. We have identified and fixed
certain of our operational issues which should enable operations to
produce in line with usual standards. Moreover we are starting to see
the benefits of the measures we have taken to improve our portfolio of
assets, a good example being the Tissue Papers Group. In Europe, the
economic uncertainty poses unique challenges in the short term but we
believe we have the right platform to face this situation.



We will likely continue to face high variable costs and a strong
Canadian dollar. After a slight increase in the beginning of the year,
we expect the pricing environment for recycled fibre to be more
favorable during the next quarter."



Financial Summary



















































































































Selected consolidated information

��

��

��

(in millions of Canadian dollars, except amounts per share) (unaudited)

Q1/2012

Q1/2011

Q4/2011

��

��

��

��

Sales

891

774

913

Excluding specific items 1

��

��

��

��

Operating income before depreciation and amortization (OIBD or EBITDA)

72

37

51

��

Operating income

26

1

-

��

Net earnings (loss)

4

1

(4)

��

��

per common share

$0.04

$0.01

$(0.04)

��

Cash flow from continuing operations (adjusted)

48

15

40

As reported

��

��

��

��

Operating income before depreciation and amortization (OIBD or EBITDA)

75

30

37

��

Operating income (loss)

29

(6)

(14)

��

Net earnings (loss)

6

(8)

5

��

��

per common share

$0.06

$(0.08)

$0.05

��

Cash flow from continuing operations (adjusted)��

48

15

35


Note 1 - see the supplemental information on non-IFRS measures.



Results analysis for the three-month period ended March 31, 2012
(compared to the previous year)



In comparison with the same period last year, sales rose by 15% to $891
million
as of result of higher selling prices, the net contribution of
business acquisitions over divestitures and the full consolidation of
the results of Reno de Medici ("RdM") since Q2-2011 that more than
offset lower volumes.



The above-mentioned factors combined with lower raw material costs
resulted in operating income, excluding specific items, amounting to
$26 million compared to $1 million in Q1-2011. On a segmented basis,
our Containerboard sector posted similar profitability. Our Tissue
Papers and Specialty Products sectors surpassed 2011 first quarter's
results due to improved productivity and lower recycled fiber costs.
Our Boxboard sector in Europe benefited from the full consolidation
from RdM since Q2-2011. When including specific items, the operating
income amounted to $29 million in comparison to a loss of $6 million in
the same period of last year.



In the first quarter of 2012, these specific items impacted our
operating income and/or net earnings (before tax):




  • a $2 million unrealized gain on financial instruments (impact on
    operating income and net earnings);


  • a $1 million gain on disposal and others (operating income and net
    earnings);


  • a $2 million foreign exchange gain on long-term debt and financial
    instruments (net earnings);


  • a $2 million after-tax loss included in discontinued operations (net
    earnings).



For further details, see the two following tables on IFRS and non-IFRS
measures reconciliation included herewith.



Net earnings excluding specific items amounted to $4 million ($0.04 per
share) in the first quarter of��2012 compared to net earnings of $1
million
($0.01 per share) for the same period of last year. Including
specific items, net earnings amounted to $6 million ($0.06 per share)
compared to a loss of $8 million ($0.08 per share) for the same quarter
in 2011.



Results analysis for the three-month period ended March 31, 2012
(compared to the previous quarter)



In comparison to the previous quarter, sales decreased slightly mostly
due the impact of lower average selling prices caused by a less
favorable product mix and the appreciation of the Canadian dollar.
Despite lower sales, operating income and net earnings improved
primarily due to lower fibre costs that more than offset a decrease in
average selling prices and higher energy costs.



Net debt increased by $39 million to $1,524 million as a result of
capital investments and a build-up in working capital. Of this amount,
$173 million is non-recourse



Dividend on common shares and normal course issuer bid



The Board of Directors of Cascades declared a quarterly dividend of
$0.04 per share to be paid June 7, 2012 to shareholders of record at
the close of business on May 25, 2012. This dividend paid by Cascades
is an "eligible dividend" as per the Income Tax Act (Bill C-28,
Canada).



In the first quarter of 2012, Cascades purchased for cancellation
512,200 shares at an average price of $4.34 representing an aggregate
amount of approximately $2.2 million.



Supplemental information on non-IFRS measures



Operating income before depreciation and amortization, earnings before
interests, taxes, depreciation and amortization, operating income and
cash flow from operations are not measures of performance under IFRS.
The Corporation includes operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations because
they are measures used by management to assess the operating and
financial performance of the Corporation's operating segments.
Additionally, the Corporation believes that these items provide
additional measures often used by investors to assess a company's
operating performance and its ability to meet debt service
requirements. However, operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations do not
represent, and should not be used as a substitute for net earnings or
cash flows from operating activities as determined in accordance with
IFRS, and they are not necessarily an indication of whether cash flow
will be sufficient to fund our cash requirements. In addition, our
definition of operating income before depreciation and amortization,
earnings before interests, taxes, depreciation and amortization,
operating income and cash flow from operations may differ from those of
other companies. Cash flow from operations is defined as cash flow from
operating activities as determined in accordance with IFRS excluding
the change in working capital components.



Operating income before depreciation and amortization excluding specific
items, earnings before interests, taxes, depreciation and amortization
excluding specific items, operating income excluding specific items,
net earnings excluding specific items, net earnings per common share
excluding specific items and cash flow from operations excluding
specific items are non-IFRS measures. The Corporation believes that it
is useful for investors to be aware of specific items that have
adversely or positively affected its IFRS measures, and that the above
mentioned non-IFRS measures provide investors with a measure of
performance�� with which to compare its results between periods without
regard to these specific items. The Corporation's measures excluding
specific items have no standardized meaning prescribed by IFRS and are
not necessarily comparable to similar measures presented by other
companies and therefore should not be considered in isolation.



Specific items are defined to include charges for impairment of assets,
charges for facility or machine closures, debt restructuring charges,
gains or losses on sale of business unit, unrealized gains or losses on
derivative financial instruments that do not qualify for hedge
accounting, foreign exchange gains or losses on long-term debt and
other significant items of an unusual or non-recurring nature.



Net earnings (loss), which is a performance measure defined by IFRS is
reconciled below to operating income (loss), operating income excluding
specific items and operating income before depreciation excluding
specific items or earnings before interests, taxes, depreciation and
amortization excluding specific items:

















































































































































��

��

��

��

(in millions of Canadian dollars) (unaudited)

Q1/2012

Q1/2011

Q4/2011

��

��

��

��

Net earnings (loss)

6

(8)

5

Net loss (earnings) from discontinued operations

2

(6)

(1)

Non-controlling interest

(1)

-

-

Share of results of associates and joint ventures

(2)

(8)

(3)

Provision for (recovery of) income taxes

1

(14)

(31)

Foreign exchange loss (gain) on long-term debt and financial instruments

(2)

5

(9)

Financing expense

25

25

25

��

��

��

��

Operating income (loss)

29

(6)

(14)

Specific items :

��

��

��

Inventory adjustment resulting from business acquisition

-

-

4

Loss (gain) on acquisitions, disposals and others

(1)

1

(38)

Impairment charges

-

1

44

Closure and restructuring costs

-

3

3

Unrealized loss (gain) on financial instruments

(2)

2

1

��

(3)

7

14

��

��

��

��

Operating income - excluding specific items

26

1

-

Depreciation and amortization

46

36

51

Operating income before depreciation and amortization (OIBD or EBITDA)

- excluding specific items

72

37

51







The following table reconciles net earnings (loss) and net earnings
(loss) per share to net earnings (loss) excluding specific items and
net earnings (loss) per share excluding specific items:









































































































































































��

��

��

��

(in millions of Canadian dollars, except amounts per share) (unaudited)

Net earnings (loss)

��

Net earnings (loss)��per share 1

��

Q1/2012

Q1/2011

Q4/2011

��

Q1/2012

Q1/2011

Q4/2011

��

��

��

��

��

��

��

��

As per IFRS

6

(8)

5

��

$0.06

$(0.08)

$0.05

Specific items :

��

��

��

��

��

��

��

Inventory adjustment resulting from business acquisition

-

-

4

��

$ -

$ -

$0.04

Loss (gain) on acquisitions, disposals and others

(1)

1

(38)

��

$(0.01)

$0.01

$(0.40)

Impairment charges

-

1

44

��

$ -

$0.01

$0.34

Closure and restructuring costs

-

3

3

��

$ -

$0.02

$0.02

Unrealized loss (gain) on financial instruments

(2)

2

1

��

$(0.01)

$0.02

$0.01

Foreign exchange loss (gain) on long-term debt and financial instruments

(2)

5

(9)

��

$(0.02)

$0.04

$(0.08)

Share of results of associates, joint ventures and non-controlling
interest

-

-

(2)

��

$ -

$ -

$(0.02)

Included in discontinued operations, net of tax

2

(1)

(1)

��

$0.02

$(0.01)

$ -

Tax effect on specific items and other tax adjustments

1

(2)

(11)

��

��

��

��

��

(2)

9

(9)

��

$(0.02)

$0.09

$(0.09)

Excluding specific items

4

1

(4)

��

$0.04

$0.01

$(0.04)


��Note 1 - specific amounts per share are calculated on an after-tax
basis.



The following table reconciles cash flow provided by (used from)
operating activities to cash flow (adjusted) from operations excluding
specific items:































































��

��

��

Cash flow from operations

(in millions of Canadian dollars) (unaudited)

Q1/2012

Q1/2011

Q4/2011

��

��

��

��

Cash flow provided by (used from) operating activities

24

(12)

102

Changes in non-cash working capital components

24

27

(67)

Cash flow (adjusted) from operations

48

15

35

Specific items, net of current income tax

��

��

��

Closure and restructuring costs

-

-

5

Excluding specific items

48

15

40







CONSOLIDATED BALANCE SHEETS








































































































































































































































(in millions of Canadian dollars) (unaudited)

March 31,

2012

December 31,

2011

Assets

��

��

Current assets

��

��

Cash and cash equivalents

11

12

Cash reserved for business aquisition1

14

-

Accounts receivable

553

535

Current income tax assets

25

24

Inventories

530

516

Financial assets

30

6

Assets held for sale

11

12

��

1,174

1,105

Long-term assets

��

��

Investments in associates and joint ventures

243

219

Property, plant and equipment

1,689

1,703

Intangible assets

185

185

Financial assets

12

25

Other assets

45

44

Deferred income tax assets

122

119

Goodwill and others

329

328

��

3,799

3,728

Liabilities and Equity

��

��

Current liabilities

��

��

Bank loans and advances

97

90

Trade and other payables

545

539

Current income tax liabilities

3

2

Current portion of provisions for contingencies and charges

2

5

Current portion of financial liabilities and other liabilities

83

20

Current portion of long-term debt

56

49

��

786

705

Long-term liabilities

��

��

Long-term debt

1,396

1,358

Provisions for contingencies and charges

35

33

Financial liabilities

61

111

Other liabilities

258

249

Deferred income tax liabilities

105

107

��

2,641

2,563

Equity attributable to Shareholders

��

��

Capital stock

483

486

Contributed surplus

15

14

Retained earnings

608

615

Accumulated other comprehensive loss

(82)

(86)

��

1,024

1,029

Non-controlling interest

134

136

Total equity

1,158

1,165

��

3,799

3,728


1�� As of March 31, 2012, $14 million of cash is reserved for the
acquisition of Bird Packaging Limited closed on April 1, 2012.






CONSOLIDATED STATEMENT OF EARNINGS


















































































































































































For the 3-month periods ended March 31,

(in millions of Canadian dollars, except per share amounts and number of
shares) (unaudited)

2012

2011

Sales

891

774

Cost of sales and expenses

��

��

Cost of sales (including depreciation and amortization of $46 million;
2011-$36��million)

770

697

Selling and administrative expenses

94

77

Loss (gain) on disposals and others

(1)

1

Impairment charges and restructuring costs

-

4

Foreign exchange loss

1

-

Loss (gain) on derivative financial instruments

(2)

1

��

862

780

Operating income (loss)

29

(6)

Financing expense

25

25

Foreign exchange loss (gain) on long-term debt and financial instruments

(2)

5

Profit (loss) before income taxes

6

(36)

Provision for (recovery of) income taxes

1

(14)

Share of results of associates and joint ventures

(2)

(8)

Net earnings (loss) from continuing operations including non-controlling

interest for the period

7

(14)

Net earnings (loss) from discontinued operations for the period

(2)

6

Net earnings (loss) including non-controlling interest for the period

5

(8)

Net loss attributable to non-controlling interest

(1)

-

Net earnings (loss) attributable to Shareholders for the period

6

(8)

Net earnings (loss) from continuing operations per common share

��

��

��

Basic

$0.08

($0.15)

��

Diluted

$0.08

($0.15)

Net earnings (loss) per common share

��

��

��

Basic

$0.06

($0.08)

��

Diluted

$0.06

($0.08)

Weighted average basic number of common shares outstanding

94,497,766

96,606,421

��

��

��

Net earnings (loss) attributable to Shareholders:

��

��

��

Continuing operations

8

(14)

��

Discontinued operations

(2)

6

Net earnings (loss)

6

(8)







CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS





















































































































































For the 3-month periods ended March 31,

(in millions of Canadian dollars)

(unaudited)

2012

2011

Net earnings (loss) including non-controlling interest for the period

5

(8)

Other comprehensive income (loss)

��

��

��

Translation adjustments

��

��

��

��

Change in foreign currency translation of foreign subsidiaries

(5)

(9)

��

��

Change in foreign currency translation related to net investment hedging
activities

8

15

��

��

Income taxes

(1)

(2)

��

Cash flow hedges

��

��

��

��

Change in fair value of foreign exchange forward contracts

5

(1)

��

��

Change in fair value of interest rate swaps

3

1

��

��

Change in fair value of commodity derivative financial instruments

(2)

4

��

��

Income taxes

(3)

(1)

��

Actuarial loss on post-employment benefit obligations

(14)

-

��

��

Income taxes

4

-

��

Available-for-sale financial assets

(1)

-

Other comprehensive income (loss)

(6)

7

Comprehensive loss including non-controlling interest for the period

(1)

(1)

Comprehensive income (loss) attributable to non-controlling interest for the period

(1)

-

Comprehensive income (loss) attributable to Shareholders for the period

-

(1)

��

��

��

Comprehensive income (loss) attributable to Shareholders:

��

��

��

Continuing operations

2

(7)

��

Discontinued operations

(2)

6

Comprehensive income (loss)

-

(1)







CONSOLIDATED STATEMENTS OF EQUITY






































































































































































































































��

��

For the 3-month period ended March 31, 2012

(in millions of Canadian dollars)

(unaudited)

Capital

stock

Contributed

surplus

Retained

earnings

Accumulated

other

comprehensive

loss

Total equity

attributable to

Shareholders

Non-controlling

interest

Total

equity

Balance���Beginning of period

486

14

615

(86)

1,029

136

1,165

Comprehensive income (loss)

��

��

��

��

��

��

��

��

Net earnings (loss)

-

-

6

-

6

(1)

5

��

Other comprehensive income (loss)

-

-

(10)

4

(6)

-

(6)

��

-

-

(4)

4

-

(1)

(1)

Dividends

-

-

(4)

-

(4)

-

(4)

Redemption of common shares

(3)

1

-

-

(2)

-

(2)

Acquisition of non-controlling interest

-

-

1

-

1

(1)

-

Balance���End of period

483

15

608

(82)

1,024

134

1,158

��

��

��

��

��

��

��

��

��

For the 3-month period ended March 31, 2011

(in millions of Canadian dollars)

(unaudited)

Capital

stock

Contributed

surplus

Retained

earnings

Accumulated

other

comprehensive

loss

Total equity

attributable to

Shareholders

Non-controlling

interest

Total

equity

Balance���Beginning of period

496

14

576

(37)

1,049

23

1,072

Comprehensive income (loss)

��

��

��

��

��

��

��

��

Net loss

-

-

(8)

-

(8)

-

(8)

��

Other comprehensive income

-

-

-

7

7

-

7

��

-

-

(8)

7

(1)

-

(1)

Dividends

-

-

(4)

-

(4)

-

(4)

Stock options

-

(1)

-

-

(1)

-

(1)

Redemption of common shares

(1)

-

-

-

(1)

-

(1)

Balance���End of period

495

13

564

(30)

1,042

23

1,065







CONSOLIDATED STATEMENTS OF CASH FLOWS
































































































































































































































For the 3-month periods ended March 31,

(in millions of Canadian dollars)

(unaudited)

2012

2011

Operating activities from continuing operations

��

��

Net earnings (loss) attributable to Shareholders for the period

6

(8)

Net loss (earnings) from discontinued operations for the period

2

(6)

Net earnings (loss) from continuing operations

8

(14)

Adjustments for

��

��

��

Financing expense

25

25

��

Depreciation and amortization

46

36

��

Loss (gain) on disposals and others

(1)

1

��

Impairment charges and restructuring costs

-

4

��

Loss (gain) on derivative financial instruments

(2)

2

��

Foreign exchange loss (gain) on long-term debt and financial instruments

(2)

5

��

Provision for (recovery of) income taxes

1

(14)

��

Share of results of associates and joint ventures

(2)

(8)

��

Non-controlling interest

(1)

-

��

Net financing expense paid

(15)

(17)

��

Income taxes paid

(4)

(3)

��

Others

(5)

(2)

��

48

15

Changes in non-cash working capital components

(24)

(27)

��

24

(12)

Investing activities from continuing operations

��

��

Purchase of investments in associates and joint ventures

(19)

(2)

Purchase of property, plant and equipment

(48)

(35)

Proceeds on disposal of property, plant and equipment

5

-

Cash reserved for business acquisition

(14)

-

Change in other assets

(4)

(8)

��

(80)

(45)

Financing activities from continuing operations

��

��

Bank loans and advances

6

4

Change in revolving credit facilities

81

51

Purchase of senior notes

(3)

-

Payments of other long-term debt

(23)

(2)

Redemption of common shares

(2)

(1)

Dividends paid to Corporation's Shareholders

(4)

(4)

��

55

48

Change in cash and cash equivalents during the period from continuing operations

(1)

(9)

Change in cash and cash equivalents from discontinued operations, including

proceeds on disposal during the period

-

13

Net change in cash and cash equivalents during the period

(1)

4

Cash and cash equivalents���Beginning of period

12

6

Cash and cash equivalents���End of period

11

10







SEGMENTED INFORMATION



In 2012, the Corporation changed the structure of its internal
organization in a manner that caused the composition of its reportable
segment to change. As a result, the Corporation modified its segmented
information disclosure for the current period and restated prior
periods. Containerboard and Boxboard North America manufacturing and
converting are now presented within one segment. Boxboard European
activities are reported as a separate segment.



The Corporation's operations are managed in four segments:
Containerboard, Boxboard Europe, Specialty Products (which consists of
the packaging products of the Corporation) and Tissue Papers.







































































































































































































































��

SALES

For the 3-month periods ended March 31,

(in millions of Canadian dollars)

(unaudited)

2012

2011

Packaging Products

��

��

��

Containerboard

284

344

��

Boxboard Europe

204

62

��

Specialty Products

202

202

��

Intersegment sales

(18)

(27)

��

672

581

Tissue Papers

229

199

Intersegment sales and others

(10)

(6)

Total

891

774

��

��

��

��

OPERATING INCOME (LOSS)

BEFORE DEPRECIATION AND

AMORTIZATION

For the 3-month periods ended March 31,

(in millions of Canadian dollars)

(unaudited)

2012

2011

Packaging Products

��

��

��

Containerboard

24

13

��

Boxboard Europe

13

4

��

Specialty Products

11

7

��

48

24

Tissue Papers

33

10

Corporate

(6)

(4)

Operating income before depreciation and amortization

75

30

Depreciation and amortization

(46)

(36)

Financing expense

(25)

(25)

Foreign exchange (loss) gain on long-term debt and financial instruments

2

(5)

Profit (loss) before income taxes

6

(36)

��

��

��

��

PURCHASE OF PROPERTY,

PLANT AND EQUIPMENT

For the 3-month periods ended March 31,

(in millions of Canadian dollars)

(unaudited)

2012

2011

Packaging Products

��

��

��

Containerboard

14

8

��

Boxboard Europe

5

1

��

Specialty Products

3

6

��

22

15

Tissue Papers

8

6

Corporate

3

2

Total purchases

33

23

Proceeds on disposal of property, plant and equipment

(5)

-

��

28

23

Purchase of property, plant and equipment included in trade and other
payables

��

��

��

Beginning of period

25

18

��

End of period

(10)

(6)

Purchases of property, plant and equipment net of proceeds on disposals

43

35







Founded in 1964, Cascades produces, converts and markets packaging and
tissue products that are composed mainly of recycled fibres. The
Corporation employs more than 12,000 employees, who work in more than
100 units located in North America and Europe. With its management
philosophy, half a century of experience in recycling, and continuous
efforts in research and development as driving forces, Cascades
continues to serve its clients with innovative products. Cascades'
shares trade on the Toronto Stock Exchange, under the ticker symbol
CAS.



Certain statements in this release, including statements regarding
future results and performance, are forward-looking statements (as such
term is defined under the Private Securities Litigation Reform Act of
1995) based on current expectations. The accuracy of such statements is
subject to a number of risks, uncertainties and assumptions that may
cause actual results to differ materially from those projected,
including, but not limited to, the effect of general economic
conditions, decreases in demand for the Corporation's products,
increases in raw material costs, fluctuations in selling prices and
adverse changes in general market and industry conditions and other
factors listed in the Corporation's Securities and Exchange Commission
filings.



��



��



��






For further information:

Media
Hubert Bolduc
Vice-President, Communications and Public Affairs
514 912-3790

Investors
Riko Gaudreault
Director, Investor relations
514��282-2697

Source:
Allan Hogg
Vice-President and Chief Financial Officer









No comments:

Post a Comment